These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31688253)

  • 1. MELD-plus: a call for an additional external validation.
    Kartoun U
    Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1603. PubMed ID: 31688253
    [No Abstract]   [Full Text] [Related]  

  • 2. Keeping high model for end-stage liver disease score liver transplantation candidates alive.
    O'Leary JG; Orloff SL; Levitsky J; Martin P; Foley DP
    Liver Transpl; 2015 Nov; 21(11):1428-37. PubMed ID: 26335696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The true merits of liver allocation according to MELD scores: survival after transplantation tells only one side of the story.
    Metselaar HJ; Lerut J; Kazemier G
    Transpl Int; 2011 Feb; 24(2):132-3. PubMed ID: 21208292
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores.
    Wronka KM; Grąt M; Stypułkowski J; Bik E; Krasnodębski M; Masior Ł; Grąt K; Patkowski W; Krawczyk M
    Ann Transplant; 2017 Apr; 22():251-256. PubMed ID: 28439063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Situ Split Liver Transplantation for 2 Adult Recipients: A Single-Center Experience.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Kim WJ; Kang WH; Kim SH; Lee SG
    Ann Transplant; 2017 Apr; 22():230-240. PubMed ID: 28428535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does model for end-stage liver disease (MELD) require modification?
    Desai HG
    J Assoc Physicians India; 2011 Jun; 59():372-3. PubMed ID: 21751591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Model for End-stage Liver Disease (MELD) score on liver transplantation in Greece.
    Karapanagiotou A; Kydona C; Dimitriadis C; Papadopoulos S; Theodoridou T; Tholioti T; Fouzas G; Imvrios G; Gritsi-Gerogianni N
    Transplant Proc; 2014 Nov; 46(9):3212-5. PubMed ID: 25420862
    [TBL] [Abstract][Full Text] [Related]  

  • 12.  Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Xu MQ; Wang WT; Wei YG
    Ann Hepatol; 2012; 11(4):471-7. PubMed ID: 22700628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How much is too much?
    McCashland TM
    Liver Transpl; 2011 Feb; 17(2):102-3. PubMed ID: 21280181
    [No Abstract]   [Full Text] [Related]  

  • 16. Is MELD fit enough?
    O'Leary JG; Trotter JF
    Gastroenterology; 2011 Jun; 140(7):1871-4. PubMed ID: 21521638
    [No Abstract]   [Full Text] [Related]  

  • 17. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Outcomes in Split Compared With Whole Liver Transplantation.
    Chul Yoon K; Song S; Jwa EK; Lee S; Man Kim J; Kim OK; Kyun Hong S; Yi NJ; Lee KW; Soo Kim M; Hwang S; Suh KS; Lee SK
    Liver Transpl; 2018 Oct; 24(10):1411-1424. PubMed ID: 29747216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Liver Transplant Recipients With Model for End-Stage Liver Disease Exception: Single-Center Experience in the Northeast of Brazil.
    Coelho GR; Praciano AM; Viana GNR; Lima CA; Feitosa Neto BA; Garcia JHP
    Transplant Proc; 2018 Jun; 50(5):1428-1430. PubMed ID: 29880366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictors of mortality among liver transplant candidates].
    Erez D; Ben Ari Z; Michowitz R; Mor E
    Harefuah; 2011 Jan; 150(1):16-20, 70, 69. PubMed ID: 21449150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.